Efferocytosis

Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications

Gupta N, Liu Y, Cai B. Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications. Immunohorizons. 2026 Feb 17;10(SI):vlag002. doi: 10.1093/immhor/vlag002. PMID: 41774843; PMCID: PMC12955849.

By afschroeder • March 4, 2026

Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism

Ciullo A, Li L, Li C, Tsi K, Farrell C, Pellegrini M, Marbán E, Ibrahim AGE. Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated[...]

By sjmartinez • June 13, 2024